6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
20m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
21m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
45m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
45m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
45m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Hansa Biopharma Ab (F:24H) — investor relations, events, news, and company updates on 6ix.

Latest News

Hansa Biopharma publishes 2025 Annual and Sustainability Reports

PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026

Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results

KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer

Financials

Revenue

€178.61 M

Market Cap

€284.84 M

EPS

-0.60

Community Chat

Ask AI